Upload Layout: V ontheway （V 在途中）
The United States Centers for Disease Control and Prevention (CDC) says a young boy between the age of 5 and 11 died 13 days after his first Pfizer-BioNTech COVID-19 vaccine shot.
Despite the boy’s death, the CDC vaccine advisory panel and the panel’s director Dr Rochelle Walensky signed off on a third COVID-19 vaccine dose for the age group.
Dr Tom Shimabukuro, a member of the CDC’s vaccine safety team, reported the death during a virtual meeting hosted by the Advisory Committee on Immunization and Practices (ACIP).
The committee, without discussing the death, concluded that the benefits of the Pfizer COVID-19 vaccine outweighed the risks.
According to Dr Shimabukuro’s report, the young boy developed a fever 12 days after his first vaccination. One day later, he died after suffering from vomiting and abdominal pain. Evidence suggests he also had myocarditis, or heart inflammation, a severe COVID-19 vaccine reaction more likely to develop among male recipients.
“This patient had a rapid clinical course. From the time they started experiencing their abdominal pain day 13 after dose one until the time they were brought into the [emergency department] and subsequently died was on the order of a couple of hours,” said Dr Shimabukuro.
“Histopathological evidence of myocarditis was present on autopsy, and that was resolved to be the cause of death.”
Dr Shimabukuro added that the CDC’s infectious disease pathology branch conducted tests on the young male but could not find proof of viral infection at the time of his death.
Data from the CDC on Friday reveals a total of 1,277,980 COVID-19 vaccine adverse events reported to VAERS between December 14, 2020, and May 20, 2022.
According to Children’s Health Defense, there have been 9,972 additional adverse event reports over the last week.
Meanwhile, on May 23 in Britain, the final hearing began for an investigation into the death of Jack Hurn, a 26-year-old male who died in 2021 from brain blood clots 13 days after his AstraZeneca COVID-19 vaccine dose.
The hearing is expected to span over three days.
Studies suggest the Astrazeneca shot poses significant blood clot risks for recipients below 30 years.
Mr Hurn’s family hopes the investigation will give answers to the circumstances of his death. For example, the reason why healthcare providers declined his request for a Pfizer shot instead of the AstraZeneca version.
Vaccine centre staff where Mr Hurn and his girlfriend were vaccinated reportedly told the couple that the Pfizer vaccine was not available and that the AstraZeneca vaccine was safe.